Literature DB >> 8846474

Percutaneous transhepatic treatment of a posttransplant portal vein thrombosis and a preexisting spontaneous splenorenal shunt.

J I Bilbao1, M Arias, J I Herrero, A Iglesias, F Martínez Regueira, P L Alejandre, J M Longo, J Quiroga.   

Abstract

Percutaneous transhepatic treatment of portal vein thrombosis after liver transplantation in a patient with a preexisting high volume spontaneous splenorenal shunt is presented. Local thrombolysis with urokinase and balloon angioplasty of the main portal vein stenosis were performed followed by shunt embolization to restore hepatopetal portal blood flow.

Entities:  

Mesh：

Year:  1995        PMID： 8846474     DOI： 10.1007/bf00203685

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  17 in total

1.  Fibrinolytic therapy for portal vein thrombosis.

Authors:  T Bizollon; F Bissuel; L Detry; C Trepo
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

2.  Vascular complications following orthotopic liver transplantation: outcome and the role of urgent revascularization.

Authors:  W C Marujo; A N Langnas; R P Wood; R J Stratta; S Li; B W Shaw
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Treatment of portal vein obstruction by percutaneous transhepatic angioplasty.

Authors:  R Uflacker; M A Alves; G G Cantisani; H P Souza; J Wagner; L F Moraes
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

4.  Transhepatic embolization of superior mesenteric varices in portal hypertension.

Authors:  C K Ozaki; M Hansen; S Kadir
Journal:  Surgery       Date:  1989-03       Impact factor: 3.982

5.  Acute portal vein thrombosis: a cause of rapid deterioration of liver function, treatable by thrombectomy and transplantation.

Authors:  M E Schwartz; S Emre; E Mor; E Katz; C M Miller
Journal:  Transplant Proc       Date:  1993-04       Impact factor: 1.066

6.  [Influence of the sclerosing of esophageal varices on portal pressure and azygos venous blood flow].

Authors:  P Bourbon; J P Zarski; P Kitmacher; P Bourlard; J Machecourt; B Denis; M Rachail
Journal:  Gastroenterol Clin Biol       Date:  1990

7.  [Segmental portal hypertension caused by splenic vein thrombosis].

Authors:  G Olivero; A Franchello; E Visetti; E Orlando; F Enrichens; A Foco; F Ibba
Journal:  Minerva Chir       Date:  1990-01       Impact factor: 1.000

8.  Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: successful treatment by transhepatic shunt embolization.

Authors:  D Vavasseur; C Duvoux; D Cherqui; S Derhy; A Rahmouni; D Dhumeaux; D Mathieu
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Sep-Oct       Impact factor: 2.740

9.  Transjugular intrahepatic portocaval shunt after thrombus disruption in partially thrombosed portal veins.

Authors:  J I Bilbao; J M Longo; H Rousseau; V de Villa; F Mansilla; J Alvarez-Cienfuegos; F Joffre; J Prieto
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Mar-Apr       Impact factor: 2.740

10.  Liver transplantation in patients with portal vein thrombosis and central portacaval shunts.

Authors:  A Shaked; R W Busuttil
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969
View more
  1 in total

1.  Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients.

Authors:  Xingshun Qi; Guohong Han; Zhanxin Yin; Chuangye He; Jianhong Wang; Wengang Guo; Jing Niu; Wei Zhang; Ming Bai; Daiming Fan
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.